
Tag: research grant
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-
$500,000 Research grant to combat cancer treatment resistance
SAN CARLOS, Calif. and WASHINGTON, Feb. 6, 2020 /PRNewswire/ — ALK Positive (a patient-led group of 1,900+ lung cancer patients and caregivers in 50+ countries) and GO2 Foundation for Lung Cancer (a global lung cancer advocacy and education organization) are awarding a two-year, $500,000 Research Collaboration Grant to two renowned lung cancer researchers dedicated to overcoming treatment resistance. This grant funds research to help break down…
-
LUNGevity and ALK Positive Inc. partner to fund $1 Million in Lung Cancer Research Awards
LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards Collaboration for patient-driven research that has lifesaving potential FOR IMMEDIATE RELEASE Media Contact: Linda Wengerlwenger@LUNGevity.org(973) 449-3214 WASHINGTON, DC (January 21, 2020) — LUNGevity Foundation is partnering for the second time with patient-led group ALK Positive to support the ALK-positive…
-
ALK Positive Inc. partners with GO2 Foundation for groundbreaking ALK Research
We are excited to partner with the new GO2 Organization. With this new powerhouse partner, we will fund more research, lower our overhead costs, and provide more treatment for this disease. We will launch a new fundraising portal this month. More details are soon to come with full research proposal announcements. FAQ’s How will the…
-
$600,000 Granted in the First-Ever Research Awards funded by ALK Positive Inc.
read the full press release here ALK-positive lung cancer patients take matters into their own hands to fund research with the potential to save their lives Each of these two-year awards is for up to $200,000, with monies raised by ALK Positive and Lungevity. The three projects selected aim to understand how immunotherapy can be used…
